Raphael Erez

Avg. Two Year Performance

(29%) Avg. Purchase Return
(13%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%17%64%(11%)(29%)
Purchase Success Rate3 of 52 of 54 of 51 of 50 of 5
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2
Health Services » Medical Laboratories & Research

Chief Executive Officer, Director:

Holdings: 1.15M shares


Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount